SCHEMBL5495924

SCHEMBL5495924

CCOC(=O)CCNC(=O)[C@H](Cc1ccccc1)NCC(=O)OCC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR142 Q7Z601 1/20 0.52
PPID Q08752 1/20 0.49
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C19 P33261 1/20 0.47
MMP8 P22894 1/20 0.46
BCHE P06276 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
POLB P06746 2/20 0.45
MEN1 O00255 1/20 0.44
ALDH1A1 P00352 1/20 0.44
HPGD P15428 1/20 0.44
KMT2A Q03164 1/20 0.44
LTA4H P09960 2/20 0.44
HRH4 Q9H3N8 1/20 0.43
TSHR P16473 1/20 0.43
ACHE P22303 1/20 0.43
CTSL P07711 1/20 0.43
CTSB P07858 1/20 0.43
CTSS P25774 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5495922 1.00 GPR142 (0.52) GPR142PPIDCYP3A4CYP2D6CYP2C19
SCHEMBL5497742 0.86 GPR142 (0.49) GPR142PPIDMMP8BCHEL3MBTL1
SCHEMBL27874903 0.84 MMP8 (0.67) PPIDCYP3A4CYP2D6CYP2C19MMP8
SCHEMBL10073607 0.83 PPID (0.54) GPR142PPIDMMP8L3MBTL1POLB
SCHEMBL17287421 0.83 PPID (0.54) GPR142PPIDMMP8POLBMEN1
SCHEMBL28801052 0.82 MMP8 (0.58) PPIDCYP3A4CYP2D6CYP2C19MMP8
SCHEMBL7386752 0.82 CYP3A4 (0.51) PPIDCYP3A4CYP2D6CYP2C19MMP8
SCHEMBL2896038 0.82 MEN1 (0.57) GPR142PPIDCYP2C19MMP8L3MBTL1
SCHEMBL2896037 0.82 MEN1 (0.57) GPR142PPIDCYP2C19MMP8L3MBTL1
SCHEMBL7348558 0.81 MME (0.48) L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7189708-B2 Topical composition for skin KAO CORPORATION (JP) 2007-03-13 US disclosed
EP-1090625-B1 Topical composition for the skin and use thereof KAO CORP (JP) 2004-12-22 EP disclosed
US-20030087833-A1 Topical composition for skin KAO CORPORATION (JP) 2003-05-08 US disclosed
US-6489291-B1 Topical composition for skin KAO CORPORATION (JP) 2002-12-03 US disclosed
EP-1090625-A2 Topical composition for the skin and use thereof Kao Corporation (JP) 2001-04-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030087833-A1 Topical composition for skin CUTA, SLC38A7, CCR8 GPR142 1372/4885PPID 3265/4885CYP3A4 2172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.